HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ilaria Conti Selected Research
Ilaria Conti Research Topics
Disease
12
Neoplasms (Cancer)
12/2021 - 01/2004
3
Sarcoma (Soft Tissue Sarcoma)
01/2019 - 07/2016
3
Multiple Myeloma
03/2017 - 09/2016
2
Melanoma (Melanoma, Malignant)
01/2020 - 07/2014
2
Thrombocytopenia (Thrombopenia)
09/2016 - 07/2014
2
Neutropenia
07/2016 - 07/2014
1
Hepatocellular Carcinoma (Hepatoma)
11/2021
1
Carcinogenesis
01/2021
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1
Leukemia
01/2021
1
Hypoxia (Hypoxemia)
01/2021
1
Obesity
01/2020
1
Alzheimer Disease (Alzheimer's Disease)
01/2020
1
Infections
01/2020
1
Stomach Neoplasms (Stomach Cancer)
02/2019
1
Adenocarcinoma
02/2019
1
Parvoviridae Infections (Parvovirus Infection)
01/2019
1
Disease Progression
01/2019
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1
Glioblastoma (Glioblastoma Multiforme)
01/2018
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2018
1
Sickle Cell Anemia (Hemoglobin S Disease)
01/2017
1
Lymphopenia (Lymphocytopenia)
09/2016
1
Febrile Neutropenia
07/2016
1
Nausea
07/2016
1
Vomiting
07/2016
1
Mucositis
07/2016
1
Thyroid Neoplasms (Thyroid Cancer)
03/2016
1
Breast Neoplasms (Breast Cancer)
01/2016
1
Leukopenia
07/2014
1
Non-Muscle Invasive Bladder Neoplasms
01/2011
Drug/Important Bio-Agent (IBA)
3
Ligands
IBA
01/2020 - 01/2004
3
LY3009120
IBA
01/2020 - 09/2015
3
Monoclonal Antibodies
IBA
02/2019 - 07/2016
3
olaratumab
IBA
01/2019 - 07/2016
3
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2019 - 07/2016
3
B-Cell Activating Factor
IBA
03/2017 - 09/2016
3
tabalumab
IBA
03/2017 - 09/2016
3
Bortezomib (Velcade)
FDA Link
03/2017 - 09/2016
3
Chemokines
IBA
01/2016 - 01/2004
2
MicroRNAs (MicroRNA)
IBA
12/2021 - 01/2020
2
Biomarkers (Surrogate Marker)
IBA
12/2021 - 11/2021
2
Dexamethasone (Maxidex)
FDA Link
Generic
03/2017 - 09/2016
1
RNA (Ribonucleic Acid)
IBA
11/2021
1
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
01/2021
1
G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
IBA
01/2021
1
Cytokines
IBA
01/2021
1
Melatonin
IBA
01/2021
1
Proteins (Proteins, Gene)
FDA Link
01/2021
1
pyridostatin
IBA
01/2020
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
02/2019
1
Immunoglobulin G (IgG)
IBA
02/2019
1
avelumab
IBA
02/2019
1
Antiviral Agents (Antivirals)
IBA
01/2019
1
Hydroxyurea (Hydrea)
FDA Link
Generic
01/2017
1
Alanine Transaminase (SGPT)
IBA
09/2016
1
Growth Factor Receptors
IBA
07/2016
1
Anthracyclines
IBA
07/2016
1
Vemurafenib
IBA
03/2016
1
Phosphotransferases (Kinase)
IBA
03/2016
1
Chemokine Receptors
IBA
01/2016
1
CC Chemokines
IBA
01/2016
1
Protein Isoforms (Isoforms)
IBA
09/2015
1
Sodium
IBA
07/2014
1
Albumins
IBA
07/2014
1
N- ((5- bromo- 2- thienyl)sulfonyl)- 2,4- dichlorobenzamide
IBA
07/2014
1
Paclitaxel (Taxol)
FDA Link
Generic
07/2014
1
Gemcitabine
FDA Link
01/2011
1
Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
IBA
06/2004
1
CCR2 Receptors
IBA
06/2004
Therapy/Procedure
7
Therapeutics
12/2021 - 01/2004
3
Drug Therapy (Chemotherapy)
02/2019 - 07/2016